Atos will launch a reverse stock split, likely to take effect by May 1, CEO Philippe Salle said on Wednesday, as the French ...

Atossa Therapeutics (NASDAQ:ATOS – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a report released on Wednesday,Benzinga reports. They currently have a ...

Atos said on Friday it is launching a reverse stock split as the French IT group aims to restore investor confidence after ...

Difficulties unpicking 25 years of technical entanglement secure £474.4M without competition Following protracted ...

Atos SE (OTCMKTS:AEXAF – Get Free Report) was the target of a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 555,600 shares, a ...

Atossa Therapeutics (ATOS) announced its strategic decision to pursue a metastatic breast cancer indication for (Z)-endoxifen. Atossa believes ...

Atos missed its annual revenue forecast on Wednesday, dented by contract terminations and market weakness, but saw improved ...

Atos on Friday said that it would exchange 10,000 old shares with a face value of less than 1 euro for one new share holding a 1 euro face value. Shares are currently valued at less than 1 European ...

Atos' market cap sits at a historical low of 315 million euros. The French IT concern now wants to massively reduce the ...

It is reminded that as part of its financial restructuring and following the completion on 18 December 2024 of the final ...

In a report released on March 6, Laurent Daure from Kepler Capital maintained a Sell rating on Atos SE (0DNH – Research Report). The company’s ...

Press Release Atos Belgium and Venator Announce the Successful Implementation of the Eviden Product Carbon Footprint Platform ...